glp 1 agonist benefits Frontiers GLP-1 Receptor Agonists in Heart
Description
Diabetes (Type 2) Available in NZ = Dulaglutide (Trulicity, weekly injection) or Liraglutide (Victoza, daily injection)
Since the FDA approved Wegovy in 2021 and Zepbound in 2023, public awareness of GLP-1 drugs have surged
Hepatology (2016) 64:202837
1 Introduction Glucagon-like peptide-1 (GLP-1) is an endogenous incretin secreted by small intestinal L cells, consisting of two bioactive isoforms: GLP-1 (7-37) and GLP-1 (7-36)
Semaglutide (Ozempic and Wegovy) resulted in a 14.9% reduction in body weight in clinical trials, while tirzepatide (Mounjaro and Zepbound) led to a 20.9% body weight reduction
When I received the devastating news, I wasnt afraid to begin treatment
